{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:21:55Z","timestamp":1758630115814},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,15]]},"DOI":"10.1086\/421954","type":"journal-article","created":{"date-parts":[[2004,10,4]],"date-time":"2004-10-04T14:49:35Z","timestamp":1096901375000},"page":"S181-S184","source":"Crossref","is-referenced-by-count":6,"title":["How to Improve the Design of Trials of Antifungal Prophylaxis among Neutropenic Adults with Acute Leukemia"],"prefix":"10.1093","volume":"39","author":[{"given":"Francesco","family":"Menichetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,10,15]]},"reference":[{"key":"key\n\t\t\t\t20171014023357_ref1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/515128","article-title":"Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy","volume":"28","author":"Rotstein","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014023357_ref2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia: results of a randomized placebo-controlled, double-blind, multicenter trial","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014023357_ref3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","article-title":"Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014023357_ref4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014023357_ref5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014023357_ref6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2141.1999.01465.x","article-title":"A randomised controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies: UK Multicentre Antifungal Prophylaxis Study Group","volume":"105","author":"Morgenstern","year":"1999","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20171014023357_ref7","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/AAC.44.7.1887-1893.2000","article-title":"Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematologic malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B","volume":"44","author":"Harousseau","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014023357_ref8","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1200\/JCO.2003.04.052","article-title":"Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients","volume":"21","author":"Glasmacher","year":"2003","journal-title":"Clin Oncol"},{"key":"key\n\t\t\t\t20171014023357_ref9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428199309067926","article-title":"Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with haematological malignancies and intensive chemotherapy. A double-blind, placebo controlled study","volume":"11","author":"Vreugdenhil","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20171014023357_ref10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/313654","article-title":"A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients","volume":"30","author":"Nucci","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014023357_ref11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-120-11-199406010-00003","article-title":"Preventing fungal infection in neutropenic patients with acute leucemia: fluconazole compared with oral amphotericin B","volume":"120","author":"Menichetti","year":"1994","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014023357_ref12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000040923","article-title":"Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: meeting report","volume":"101","author":"Prentice","year":"1999","journal-title":"Acta Haematol"},{"key":"key\n\t\t\t\t20171014023357_ref13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/clinids\/18.5.793","article-title":"Evolving risk factors for invasive fungal infections\u2014all neutropenic patients are not the same","volume":"18","author":"Walsh","year":"1994","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014023357_ref14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/21.2.361","article-title":"Invasive fungal diseases in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen","volume":"21","author":"Bow","year":"1995","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014023357_ref15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/infdis\/142.4.503","article-title":"The value of fungal surveillance cultures as predictors of systemic fungal infections","volume":"142","author":"Sandford","year":"1980","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014023357_ref16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF02013057","article-title":"Predictive value of surveillance cultures for systemic infection due to Candida species","volume":"6","author":"Pfaller","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014023357_ref17","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/1097-0142(19891115)64:10<2030::AID-CNCR2820641011>3.0.CO;2-2","article-title":"Prospective study of Candida colonization and systemic infection in neutropenic patients: a retrospective study","volume":"64","author":"Martino","year":"1989","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20171014023357_ref18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/BF02111339","article-title":"Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients","volume":"13","author":"Martino","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014023357_ref19","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1182\/blood.V86.6.2063.bloodjournal8662063","article-title":"Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal","volume":"86","author":"Uzun","year":"1995","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014023357_ref20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/39\/Supplement_4\/S181\/20905767\/39-Supplement_4-S181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T07:57:58Z","timestamp":1585900678000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/39\/Supplement_4\/S181\/320986\/How-to-Improve-the-Design-of-Trials-of-Antifungal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,15]]},"references-count":20,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2004,10,15]]},"published-print":{"date-parts":[[2004,10,15]]}},"URL":"https:\/\/doi.org\/10.1086\/421954","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,10,15]]},"published":{"date-parts":[[2004,10,15]]}}}